查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1136913

2022-2029 年患者登記軟件的全球市場

Global Patient Registry Software Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

患者註冊軟件市場的增長受到政府舉措、越來越多地採用患者註冊軟件來診斷疾病以及研發活動的推動。

電子健康記錄 (EHR) 的接受度有望推動市場增長。

在數字世界中，信息和通信技術在醫療保健行業中得到廣泛應用，以處理大數據和海量健康信息。根據國際標準化組織 (ISO) 的規定，EHR 被認為是數字形式的患者數據存儲庫，可以安全地存儲和交換，並且可供多個授權用戶訪問。在醫療保健部門採用該系統將改善患者護理、最小化成本、增加收入、減少醫療事故、降低文件空間要求、數據保密、患者數據的集中管理，它具有一些優勢，例如共享醫療信息。此外，EHR 使臨床醫生能夠輕鬆分析患者數據以發現新的治療方法、發現安全問題並識別異常的臨床發現。

此外，市場參與者正在採用各種營銷策略，例如產品發布和合作。例如，2020 年 10 月，Dacima Software, Inc. 與 Movember 合作設計和開發了一個新的註冊數據庫，以啟動世界上最大的前列腺癌患者註冊網絡。同樣在 2020 年 6 月，ArborMetrix Inc.（美國）與介入放射學會（SIR）（美國）建立了合作夥伴關係。這種夥伴關係的目標是為 IR 質量登記處提供一種整合分析以改善患者護理的方法。

患者註冊軟件的高成本阻礙了市場增長

但是，全球超過 50% 的電子記錄項目未能實現預期收益。 EHR 的實施仍然是一項重大挑戰，尤其是在撒哈拉以南低收入國家的醫療保健部門。只有 15% 的低收入國家在醫療保健設施中擁有全國性的電子記錄系統。

COVID-19 影響分析

COVID-19 的出現對全球患者註冊軟件市場產生了重大影響。自 COVID-19 流行開始以來，由於其複雜和不確定的性質，COVID-19 的迅速而令人震驚的爆發已經在全球範圍內產生了對數據收集基礎設施的基本需求。從事開發數據管理解決方案的市場參與者。例如，2020 年 3 月，數據和分析技術與服務提供商 Health Catalyst, Inc. 推出了 COVID-19 註冊表、儀表板和容量規劃工具。此外，政府正在幫助控制和管理 COVID-19 的情況。例如，在伊朗，在 COVID-19 流行初期，衛生系統管理員衛生部創建了兩個信息系統來處理衛生保健中心的 COVID-19。但是，這兩個系統會收集有關 COVID-19 患者的基本信息。總體而言，COVID-19 對市場增長產生了積極影響。

全球患者註冊軟件市場報告將提供對大約 65 多個市場數據表、65 多個數字和 200 多頁（大約）的訪問。

內容

第一章市場研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 越來越多地採用 EHR 和信息技術相關服務
      • 隨著慢性病的增加，醫療保健管理變得更加複雜
    • 約束因素
      • 隱私、數據安全相關問題、缺乏熟練和訓練有素的資源
    • 影響分析

第五章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 監管分析
  • 定價分析
  • 未滿足的需求分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章。按疾病登記類型

  • 阿爾茨海默氏症
  • 糖尿病
  • 骨科
  • 心髒病學
  • 癌症
  • 其他

第 8 章按功能類型

  • 患者護理管理
  • 健康信息交換 (HIC)
  • 護理點 (POC)
  • 調查研究
  • 其他

第 9 章，最終用戶

  • 醫院
  • 製藥公司
  • 實驗室
  • 其他

第 10 章按軟件類型

  • 綜合型
  • 獨立

第 11 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 12 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 按治療類型劃分的基準

第 13 章公司簡介

  • 達西瑪軟件公司
    • 公司簡介
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • McKesson Corporation
  • Global Vision Technologies Inc.
  • ImageTrend Inc.
  • Liaison Technologies.
  • Optum Inc.
  • Phytel Inc.
  • Quintiles IMS Holdings Inc

第 14 章全球患者登記軟件市場-M

簡介目錄
Product Code: DMHCIT825

Market Overview

Patient Registry Software Market size was valued at US$ xx million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 9.2% during the forecast period (2022-2029).

Patient registry software is an automated database containing personal, medical, social, and financial data reported by healthcare professionals or patients. In addition, this software easily collects data on patients or groups of patients in clinical studies, taking a new drug or having a particular diagnosis or condition.

Market Dynamics

The patient registry software market growth is driven by government initiatives, the rising adoption of patient registry softwares for the diagnosis of disease, increase and research and development activities.

The acceptance of Electronic Health Records (EHR) is expected to drive the market growth

In the digital world, information communication technologies are commonly used and extensive in the healthcare industry to handle big data and ample health information. According to the International Organization for Standardization (ISO), EHR is considered a repository of patient data in digital form, stored and exchanged securely and accessible by multiple authorized users. Adopting this system in the healthcare sector has several advantages, such as improving patient care, minimizing cost, increasing revenue, reducing medical errors, reducing the need for file space, data confidentiality, central patient data management, and sharing medical information. In addition, the EHR enables clinicians to easily analyze patient data to discover new treatments, uncover safety issues, and identify unusual clinical findings.

In addition, the market players are adopting different market strategies, including product launches and collaboration. For instance, in October 2020, Dacima Software, Inc., with Movember, designed and developed a new registry database to launch the world's largest prostate cancer patient registry network. Also, in June 2020, ArborMetrix Inc. (US) partnered with The Society of Interventional Radiology (SIR) (US). This partnership goal is to provide the IR Quality Registry with a way to improve patient care by integrating analytics.

The high cost of Patient Registry Software will hamper the growth of the market

However, more than 50% of electronic record projects worldwide failed without providing their targeted benefits. Especially the implementation of EHR remains a major challenge in the healthcare sector in low-income countries such as Sub-Saharan countries. Merely 15% of low-income countries have nationally adopted electronic record systems in health institutions.

COVID-19 Impact Analysis

The appearance of COVID-19 considerably impacted the global patient registry software market. From the beginning of the COVID-19 pandemic, the fast and surprising outbreak of COVID-19, its complex and unspecified nature has created data collection infrastructures and has become a fundamental necessity worldwide. The market players engaged in developing solutions for the management of data. For instance, in March 2020, Health Catalyst, Inc., a provider of data and analytics technology and services, launched a COVID-19 Registry, Dashboard, and Capacity Planning Tool. In addition, the government supports controlling and managing the situation of COVID-19. For instance, in Iran, at the beginning of the COVID-19 epidemic, the Ministry of Health, as the custodian of the health system, created two information systems for addressing COVID-19 in healthcare centers. However, these two systems collect basic information about patients with COVID-19. Overall, COVID-19 positively impacted market growth.

Segment Analysis

The Point Of Care (POC) segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The Point Of Care (POC) segment is expected to boost the market over the forecast period. As per the article published in Practical Laboratory Medicine in November 2020, Accreditation and regulatory standards highlight the rising need to integrate POC Testing results into the patient's electric medical records. This promotes accessibility of POC results, the ability to monitor and trend, prevents unnecessary repeat testing and provides evidence for patient outcomes. As POC results are used to make clinical decisions, it is important to document results with associated reference intervals, units of measurement, critical values if applicable, date and time of testing, and also be traceable to device serial number, operator identification number, reagent lot number, and quality control (QC) results. POC results should also be differentiated from other central laboratory results to avoid confusion and trending results from different analytical methodologies. POC is routine in all hospitals and has become the standard for patient care in various healthcare settings.

Geographical Analysis

North America region holds the largest market share of the global patient registry software market

North America dominates the market for Patient Registry Software and is expected to show a similar trend over the forecast period. It is estimated to hold a significant market size over the forecast period (2022-2029) owing to increasing government support for the development, advanced healthcare infrastructure and point-of-care management. The development of digital infrastructure in the healthcare sector and the adoption of technological advancements by healthcare professionals and staff drive the market in the North American region.

For instance, in April 2020, the American Heart Association declared the development of a new patient registry to collect data. It helps the researchers to understand the interconnection between coronavirus, cardiovascular diseases, and related treatment protocols. Also, in February 2021, the Leukemia & Lymphoma Society (LLS) partnered with Citizen to develop a digital health solution to study the relationship between coronavirus and vaccination amongst blood cancer patients. They established LLS National Patient Registry to collect data on blood cancer patients for the study.

In addition, the market players are adopting product launches and collaboration strategies to expand their business in the North American region. For instance, in March 2021, ESO Solutions partnered with Virginia EMS Systems to deliver a statewide EMS data repository and statewide trauma registry to collect and analyze data to reveal key insights and trends. Also, in November 2020, ArborMetrix, Inc. partnered with the American Academy of Pediatrics to develop and grow a clinical registry to advance all children's health, well-being, and development.

Competitive Landscape

The patient registry software market is a moderately competitive presence of local and global companies. Some of the key players contributing to the market's growth are Dacima Software Inc, McKesson Corporation, Global Vision Technologies Inc., ImageTrend Inc., Liaison Technologies, Optum Inc., Phytel Inc., and Quintiles IMS Holdings Inc, among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the global patient registry software market.

For instance,

  • In December 2020, ImageTrend, Inc. announced the latest National Trauma Data Bank (NTDB) Data Dictionary available in the Patient Registry on January 2021.

Dacima Software Inc

Overview:

Dacima Software is a flexible company founded in 2003 and has developed advanced clinical software that helps solve the business's major strategic and operational challenges.

Product Portfolio:

DACIMA REGISTRY: The Dacima REGISTRY is a modified database creation software that permits users to produce registries and administrative databases without expertise in computer programming or database design theory.

The global Patient Registry Software market report would provide access to approximately 65+ market data tables, 65+ figures, and in the range of 200+ (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increase In Adoption Of EHR's And Information Technology Related Services
      • 4.1.1.2. Increase In The Prevalence Of The Chronic Disease Lead To Advancements In Healthcare Management
    • 4.1.2. Restraints:
      • 4.1.2.1. Privacy, Data Security-Related Issues And Lack Of Availability Of Skilled & Trained Resources
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Pricing Analysis
  • 5.5. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Disease Registry Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
    • 7.1.2. Market Attractiveness Index, By Disease Registry Type
  • 7.2. Alzheimer's Disease *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Diabetes
  • 7.4. Orthopaedics
  • 7.5. Cardiovascular
  • 7.6. Cancer
  • 7.7. Others

8. By Functionality Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
    • 8.1.2. Market Attractiveness Index, By Functionality Type
  • 8.2. Patient Care Management*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Health Information Exchange (HIC)
  • 8.4. Point Of Care (POC)
  • 8.5. Research
  • 8.6. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Pharmaceutical companies
  • 9.4. Clinical laboratories
  • 9.5. Others

10. By Software Type

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
    • 10.1.2. Market Attractiveness Index, By Software Type
  • 10.2. Integrated*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Stand-alone

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Treatment type Benchmarking

13. Company Profiles

  • 13.1. Dacima Software Inc*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. McKesson Corporation
  • 13.3. Global Vision Technologies Inc.
  • 13.4. ImageTrend Inc.
  • 13.5. Liaison Technologies.
  • 13.6. Optum Inc.
  • 13.7. Phytel Inc.
  • 13.8. Quintiles IMS Holdings Inc

LIST NOT EXHAUSTIVE

14. Global Patient Registry Software market- DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us